Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1386 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Omni Bio Pharma gets new US patent

Omni Bio said that the new patent is part of the technology licensed to Omni Bio related to one of its technology license agreements with the University of

Vertex Pharma files Telaprevir NDA to FDA

Vertex Pharma said that the NDA submission for Telaprevir is supported by results from three Phase 3 studies, Advance, Illuminate and Realize, which evaluated Telaprevir in people chronically

Nutraceutical sees rise in Q4 sales

Nutraceutical posted a net income of $3.54m for the fourth quarter 2010, or $0.34 per diluted share, compared to net income of $3.19m, or $0.29 per diluted share,

BDSI restarts Onsolis manufacturing

BDSI said that the shutdown was not related to Onsolis but involved concerns that had been expressed in a publicly available letter by the US Food and Drug

Impax initiates Welchol patent challenge

Welchol is indicated as an adjunct to diet and exercise to reduce elevated low-density lipoprotein cholesterol (LDL-C) in patients with primary hyperlipidemia (Fredrickson Type IIa). Daiichi Sankyo and

Chimerix presents CMX001 trial results

Chimerix study demonstrated that treatment with CMX001reduced mortality rates and effectively inhibited HSV replication in a mouse model of disseminated infections and central nervous system infections. Notably, orally-administered